Limitless Venture Group Inc. (LVGI) 0.0044

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Limitless Venture Group Inc. (LVGI) 0.0044 $LVGI

Limitless Venture Group Inc. Would Like to Inform All Shareholders of Its Former Subsidiary Genetically Enhanced Athletic Research Inc. (G.E.A.R.) That Product to Be Shipped to Vitamin Shoppe on Wednesday April 9, 2014
Marketwire - Wed Apr 02, 10:30AM CDT
Limitless Venture Group Inc's. (OTC Pink: LVGI) (PINKSHEETS: LVGI) today announced that its former subsidiary G.E.A.R. to ship large order to Vitamin Shoppe on Wednesday April 9, 2014. G.E.A.R. Shock Series product line to be available at every Vitamin Shoppe across the USA. The G.E.A.R. team also will be in attendance from April 3-7th at the FIBO expo in Cologne, Germany for the launch of G.E.A.R. Europe. Other developments include the finalization of distribution by BodyBuilding.com worlds #1 online retailer of sports nutrition and Nutrition Express another powerhouse online distributor. A lot more to come from G.E.A.R.

Limitless Venture Group's Stock Volume Soars On News of Hemp-Based Products
ACCESSWIRE - Wed Apr 02, 8:41AM CDT
Limitless Venture Group Inc.'s (OTCPINK: LVGI) stock volume skyrocketed Apr. 1, with 292,012,825 shares changing hands, nearly three times more than its three-month average volume of 107,767,353 shares.

Ku6 Media Co. Controlling Shareholder to Sell 41% Stake to Xu Xudong; Limitless Venture Group Announces The HempCore Health Series
ACCESSWIRE - Tue Apr 01, 11:41PM CDT
McDermott International Inc. (NYSE: MDR) - For an in-depth report on McDermott International Inc. follow: www.BullTrends.com/stockquote/MDR

Limitless Venture Group Inc. Announces Through Its Limitless Health Products Division The HempCore(TM) Health Series
Marketwire - Tue Apr 01, 8:15AM CDT
Limitless Venture Group Inc. (OTC Pink: LVGI) (PINKSHEETS: LVGI) today announced that in response to the ever popular industry trend and overwhelming suggestions from consumers and shareholders alike LVGI through its Limitless Health division has developed and about to enter into production on a line of HEMP based health products called The HempCore(TM) Health Series. This will be a series of four products all based around the health benefits derived from the use of HEMP as the main ingredient. One product will be aimed as heart health and cholesterol reduction, one towards joint pain/arthritis relief, one for brain health/cognitive function and one for anxiety relief.

King Digital Crushed In Its First Day of Trading; Exelixis Shares Fall 40 Percent
ACCESSWIRE - Wed Mar 26, 11:11PM CDT
King Digital Entertainment Plc (NYSE: KING) - For an in-depth report on King Digital Entertainment Plc follow: www.BullTrends.com/stockquote/KING

Limitless Venture Group Inc.'s New CEO Addresses Shareholders
Marketwire - Wed Feb 12, 9:25AM CST
Limitless Venture Group Inc. (OTC Pink: LVGI) new CEO, Joseph Francella, announces the following:

Limitless Venture Group Inc. Announces New CEO Joseph Francella Has Officially Taken His Post
Marketwire - Wed Jan 22, 9:51AM CST
Limitless Venture Group Inc. (OTC Pink: LVGI) - The changing of the guard has officially taken place as of Wednesday, January 15th. Exiting CEO Peter Scalise and myself, CEO Elect Joseph Francella, have collaborated on ways to increase LVGI businesses and solidify the current corporate structure for an exciting new future. Mr. Francella says, "there are many new and exciting products in the pipeline and I can't wait to bring them into fruition. I am also fully aware there are concerns with the share price and I will be studying that situation immediately along with the following areas I have targeted to ensure continued company growth and increased shareholder value and confidence.

Limitless Venture Group Inc. Announces the Hiring of New CEO Mr. Joseph Francella
Marketwire - Fri Dec 13, 8:25AM CST
Limitless Venture Group Inc's. (OTC Pink: LVGI) today announced the hiring of new CEO Joseph Francella to replace outgoing CEO Mr. Peter Scalise III who is moving over to become CEO of G.E.A.R., a company that was spun off by LVGI. Mr. Francella will begin on January 15, 2014.

Limitless Venture Group Inc. Announces a Special Website to Gauge Interest in a Potential Share Buyback Offer From the Company or Reverse Split
Marketwire - Tue Dec 10, 7:30AM CST
Limitless Venture Group Inc's. (OTC Pink: LVGI) in response to shareholder requests about the dilutive events taking place, because of the conversion of senior note holders debt to equity, is considering offering a share buyback. The buyback will be set up not as a cash buyback, but an offer to buy back all shares with an interest bearing note, at .003 (3/10 of a penny) per share plus interest. Shareholders who take advantage will receive a 12 month note for the full amount of their holdings plus 10% (ten percent) interest. Another possible option would be to enact a reverse split. LVGI has received many inquiries about whether or not the company was planning a reverse split and would like the opinion of all shareholders on the above corporate actions, before we further consider taking any actions," said CEO Peter Scalise.

Limitless Venture Group Inc. Announces It Has Launched a Renewed Effort to Begin Production on Its SLAM Infusination(TM) Product Line
Marketwire - Mon Nov 18, 8:27AM CST
Limitless Venture Group Inc.'s (OTC Pink: LVGI) CEO Peter Scalise today announced that as previously planned back in 2012 production is to begin on LVGI's SLAM Infusination(TM) product line. SLAM is a line of ready-to-drink (RTD) pre-mixed, 1.69 oz./70 proof (35% alcohol by volume) alcohol shots. Offered in six-packs, the product will be available in liquor stores in six flavors with nine more to be introduced shortly:

Limitless Venture Group Announces Spinoff of Its Genetically Enhanced Athletic Research Inc. Subsidiary
Marketwire - Tue Oct 29, 6:00AM CDT
Limitless Venture Group Inc's. (OTC Pink: LVGI) today announced it has filed a corporate action with FINRA to spin off its G.E.A.R. subsidiary. For every 300 shares of LVGI stock held on the record date of 11/4/13, LVGI shareholders will receive 1 new share of G.E.A.R. on the payment date of 11/8/13. G.E.A.R. will be spun off with the new management team in place led by current LVGI CEO Peter Scalise who will leave his post as LVGI CEO to put forth his full focus and take the reins of G.E.A.R. alongside Liz Gaspari and Kevin Levrone. G.E.A.R. has a goal to complete a traditional IPO on a major exchange within 18 months. More information about the spin-off and G.E.A.R.'s business will be made available soon through LVGI's disclosure with OTC Markets Group, Inc.

Two International Federation of Body Building (IFBB) Pros Join Limitless Venture Group's Genetically Enhanced Anabolic Research Inc. (G.E.A.R.) Sports Nutraceuticals Subsidiary Team
Marketwire - Wed Oct 09, 8:38AM CDT
Limitless Venture Group Inc.'s (OTC Pink: LVGI) G.E.A.R.(TM) sports nutraceuticals subsidiary today announced two new "ambassadors" to its growing team of IFBB pros: Aaron Clark and Justin Ray Compton.

Limitless Venture Group's Genetically Enhanced Anabolic Research Inc. (G.E.A.R.) Sports Nutraceuticals Subsidiary Has an Amazing Kickoff at Joe Weider's Olympia Weekend 2013
Marketwire - Tue Oct 08, 9:21AM CDT
Limitless Venture Group, Inc.'s (OTC Pink: LVGI) G.E.A.R. sports Nutraceuticals subsidiary today announced it was the smash break out hit of Joe Weider's Olympia Weekend 2013 in Las Vegas.

Liz Gaspari, The Most Powerful Woman In The Sports Nutrition World, Poised To Take Over The Male Dominated Sports Supplement Industry On December 1, 2013 Named President Of Limitless Venture Group Inc's G.E.A.R. Sports Nutraceutical Subsidiary
ACCESSWIRE - Thu Sep 19, 6:13AM CDT
Holbrook, NY, September 19, 2013 - (Accesswire) - Limitless Venture Group Inc's. (OTCPink: LVGI) G.E.A.R sports Nutraceuticals subsidiary a nutritional supplement company geared toward making everyday people look and feel extra-ordinary, announced today and welcomes industry icon, Liz Gaspari to the company, naming her G.E.A.R.[TM] President.

Limitless Venture Group's Genetically Enhanced Anabolic Research Inc. (G.E.A.R.) Sports Nutraceuticals Subsidiary Signs Letter of Intent for Distribution Agreement With Australia's Largest Supplement Retailer/Wholesaler
Marketwire - Wed Sep 18, 8:30AM CDT
Limitless Venture Group Inc's. (OTC Pink: LVGI) G.E.A.R sports Nutraceuticals subsidiary today announced it has signed a Letter of Intent with Australia's Flush Fitness to carry the entire G.E.A.R. line in both Australia and New Zealand.

Limitless Venture Group Inc. Addresses Shareholder Concerns Regarding Recent Common Stock Trading
Marketwire - Mon Sep 16, 9:15AM CDT
Limitless Venture Group Inc's (OTC Pink: LVGI) senior management has released a statement regarding the recent activity in its company stock, while dismayed at the downward pressure in the stock there is no fundamental or corporate event that has taken place to lend credence to the price action and volatility, we have been made aware of certain private transactions with a senior note holder of our company which resulted in the conversion into certain common shares of company stock, we have consulted with our attorney and the note holder and deem the transaction in full compliance with securities rules and regulations. We can only assume these shares were sold into the open market without regard. The current market capitalization of the company is less than a million and a half dollars. The company is reviewing all options to stabilize the market of its company shares and instill confidence in our shareholder base.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

D-Wave Investors Must Decide by Dec 15 Class Suit

Updated Category News Views 177

Facing the Class Action Deadline There's nothing like a looming deadline to stir the pot, and that's exactly what's happening with D-Wave Quantum Inc. (NASDAQ: QBTS) as it faces the heat of a class action lawsuit. Investors who got caught in the slide between February 26, 2026, and August 25, 2026, need to sharpen their pencils and mark December 15, 2026, on their...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 416

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 244

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 149

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
Tennessee's Bold Lung Cancer Trial Signals Innovation

Updated Category News Views 268

The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 245

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 267

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Air Sealing First: Boosting Home Comfort & Efficiency

Updated Category News Views 191

Everyone wants a cozy, energy-efficient home, right? Well, the first step to achieving that might just surprise you. Forget about shoving more insulation into the walls for a second; air sealing should be your starting line. That's the drum Insulation Expert Mike Mancuso is beating, and he's got a point worth considering before you touch another insulation panel. Cracking...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 233

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 260

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading

Top 5 Most Recently Viewed Articles

Astria Therapeutics Awards Stock Options for New Employees

Updated Category News Views 166

Astria Therapeutics Awards Stock Options for New Hires Astria Therapeutics, Inc. (Nasdaq: ATXS), based in Boston, is making significant strides in the realm of biopharmaceuticals. The company focuses on developing transformative therapies targeted at allergic and immunologic diseases. Recently, it granted stock options that allow employees to purchase 58,650 shares of its...

Continue Reading
Investors of Constellation Brands Have Chance for Class Action

Updated Category News Views 230

Opportunity for Class Action in Constellation Brands Lawsuit If you are an investor who has experienced significant losses with Constellation Brands, Inc. (NYSE: STZ), you may have the opportunity to take a leading role in a class action lawsuit against the company. This lawsuit is a chance for affected shareholders to voice their grievances and seek restitution for their...

Continue Reading
Bitcoin Surges to New Heights as Expectations Rise for Crypto Policies

Updated Category News Views 240

Bitcoin Soars Past $100,000 Amid Political Shifts Bitcoin has recently reached a remarkable milestone, crossing the $100,000 mark, with its price hitting $101,372.1. This surge is fueled by rising optimism regarding changes in U.S. cryptocurrency policies, especially with the upcoming presidential inauguration. Expectations of Crypto-Friendly Policies Fuel Bitcoin's Rise...

Continue Reading
Understanding the Impact of AI on Low-Wage Workers' Futures

Updated Category News Views 99

Research Insights on Low-Wage Americans and AI Recent research conducted highlights critical insights into the attitudes of low-wage Americans towards artificial intelligence, education, and their views on economic mobility. As technology continues to evolve, understanding these perspectives helps illuminate the challenges and opportunities faced by this demographic. The...

Continue Reading
GSR IV Acquisition Corp. Thrives with $200M IPO Launch

Updated Category News Views 188

GSR IV Acquisition Corp. Announces Successful IPO Pricing GSR IV Acquisition Corp. (NASDAQ: GSRF) has recently announced an exciting milestone—the pricing of its initial public offering (IPO). With units set at a price of $10.00 each, this IPO aims to raise a total of $200 million, with plans to offer 20,000,000 units to potential investors. This anticipated move is...

Continue Reading